Rep. Biggs: Big Pharma Won’t Consider Therapeutics Like HCQ or Ivermectin Because of Economic Interests

‘You’ve got to look at the money angle’

This story is cross-posted at our consumer site, Grabien News. Watch it there – without audiomarks.


BIGGS: “Thanks, lisa, good to be with you. I think he’s right, two reasons. Number one, when he talks about big pharma having other economic interests, they got on a path and they want to keep this path there and these other therapeutics aren’t really going to make them a lot of money, so you’ve got to look at the money angle for short. But then you also have to look at the efficacy of big government married to big pharma here and what you see is kind of this power, this control, this move for that. That’s also what’s going on, in my opinion.”

Video files
Audio files
Similar stories
Colbert: Fluvoxamine Isn’t Getting Any Traction from Anti-Vaxxers Like Ivermectin Because it Actually Works
Matthews: Voters Like Trump Because He’s a ‘Comic Book Hero’ and ‘Sinatra Kinda Guy’
Lawrence Jones on Left’s Socialist Push: They Don’t Like America
Billie Eilish Details Breakthrough COVID-19 Case: ‘It Is Because of the Vaccine that I’m Fine’
Cruz: ‘I Like Donald Because He’s Brash, He’s Bold and He Speaks the Truth’